Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02169778
Other study ID # 2014/754
Secondary ID
Status Completed
Phase N/A
First received June 17, 2014
Last updated April 28, 2017
Start date August 2013
Est. completion date December 2015

Study information

Verified date April 2017
Source Norwegian University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Obesity has become a global epidemic with huge public health implications. Although clinical significant weight loss can be achieved by a combination of diet and behavioral modification, strong metabolic adaptations, with increased appetite and suppressed energy expenditure, are activated, which compromise weight loss maintenance and increase the risk of relapse. The aim of this project is to compare the effects of intermittent versus continuous energy restriction on the compensatory responses previously described using two low calory diets, with a similar macronutrient distribution. More specifically, this study will analyze, in the short-term, if an intermittent energy restricted diet is associated with less appetite and low reduction in energy expenditure when compared with a continuous energy restricted diet. This project can bring large practical benefits concerning the design of weight loss programs to minimize weight relapse.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 2015
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- adult (18-50 years old)

- obese healthy volunteers (30<BMI<40 kg/m2)

- weight stable on the last three months (<2kg), not currently dieting to lose weight and with an inactive lifestyle

Exclusion Criteria:

- history of endocrine/cardiovascular/pulmonary/kidney disease

- anaemia

- milk intolerance

- depression or other psychological disorders

- eating disorders

- drug or alcohol abuse within the last two years

- current medication known to affect appetite or induce weight loss

- a planned surgery during the study period

- participating in another research study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Intermittent energy restricted diet

Continuous energy restricted diet


Locations

Country Name City State
Norway Norwegian University of Science and Technology Trondheim

Sponsors (3)

Lead Sponsor Collaborator
Norwegian University of Science and Technology Monash University, Portuguese Research Council

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Coutinho SR, Halset EH, Gåsbakk S, Rehfeld JF, Kulseng B, Truby H, Martins C. Compensatory mechanisms activated with intermittent energy restriction: A randomized control trial. Clin Nutr. 2017 Apr 7. pii: S0261-5614(17)30125-5. doi: 10.1016/j.clnu.2017.0 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Appetite related hormones Appetite-related hormones (active Ghrelin, PYY, GLP-1, CCK) will be measured in fasting and every 30 minutes up to 2,5 hours. 12 weeks after the intervention
Secondary Resting metabolic rate (RMR) RMR measured by indirect calorimetry 12 weeks after the intervention
Secondary Exercise efficiency Exercise efficiency measured by graded exercise on a bike 12 weeks after the intervention
Secondary Body composition RMR measured by indirect calorimetry 12 weeks after the intervention
Secondary Body composition RMR measured by indirect calorimetry At 6 months from baseline
Secondary Body composition RMR measured by indirect calorimetry At 1 year from baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2